What is

PathologyWatch?

Revolutionizing Pathology for Dermatologists

PathologyWatch is working with dermatology practices like yours to manage your pathology workflow using a digital model.

This helps to improve the quality of patient care, reduce costs, and open up new potential streams of revenue for clinics and hospitals. It has been shown to streamline clinical workflow by interfacing directly with your EMR of choice, resulting in brilliantly optimized joining of clinical decision-making and patient care.

PathologyWatch Mission

To preserve and extend life for patients while reducing the cost of healthcare.

Our Awesome Team

Dan Lambert

Chief Executive Officer | Cofounder

Dan Lambert received a degree from BYU in computer engineering, specializing in field-programmable gate arrays and computer vision. He earned his MBA from Harvard Business School and is a former executive at IBM. He has led multiple successful ventures and company exits to private equity. In 2018, Dan was named an Inc 500 CEO for his work on BoardVitals, a medical education company.

Greg Osmond, MD

Chief Medical Officer | Cofounder

Gregory Osmond, MD, MPH, is a board-certified pathologist and dermatopathologist. He completed a pathology residency (AP/CP) at Duke University, where he developed an interest and expertise in digital pathology while completing a GME concentration track in health policy, law and ethics focused on innovative business models and regulation associated with digital pathology. This was followed by a dermatopathology fellowship in the combined Harvard program (MGH, B&W, BID). In recent years, he has been involved with multiple pathology-related technology platforms and companies. He received a BS degree from Brigham Young University in neuroscience, a master’s degree in public health (MPH) from the University of Utah, and an MD from Duke University. He also has a significant interest in the implementation and utilization of diagnostic services in underdeveloped settings.

Michael Torno

EVP Business Development | Cofounder

Michael Torno has performed a variety of roles in the life sciences field. He previously served as the senior vice president of global clinical healthcare markets at Ascend Learning as well as the general manager of NursingCE. Mr. Torno has a BA from Kent State University in Psychology and an MA from the University of Akron in industrial/organizational psychology. He spent the early stages of his career at Arthur Andersen in a business consulting role. In 2002, he immersed himself in the healthcare sector and joined Cerner Corporation. During his tenure at Cerner, he relocated to Australia to help drive Cerner’s global expansion. Upon completion of his expatriate assignment, Mr. Torno became a partner in an infectious disease laboratory (Viracor Labs). During his tenure, the laboratory grew exponentially, multiple assays were launched, and robust operations were put in place. This laboratory continues to thrive today and is now owned by Eurofins Scientific.

April Larson, MD

VP of Client Experience & Advisory Board

Dr. Larson received her medical degree from the University of Utah and completed a research fellowship at the Tom C. Mathews Familial Melanoma Research Clinic at Huntsman Cancer Institute. After her dermatology residency at Dartmouth-Hitchcock Medical Center, she devoted herself to patient care for over 10 years. Through PathologyWatch, she sees digital pathology as key to improving dermatology diagnostics through the enhanced correlation of microscopic and clinical skin findings. As the director of the clinical advisory board and clinical implementation at PathologyWatch, she is focused on advancing patient care and access by delivering digital pathology and artificial intelligence solutions to dermatologists both nationally and globally.